NCT06410742Completed
Comprehensive Evaluation of Clinical and Biopsychosocial Characteristics in Primary Sjögren's Disease
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
Following the guidance of individuals with primary Sjögren's Syndrome who receive diagnosis, routine medical care, and treatment management, the evaluations will be performed once by the researchers and will take approximately one hour. In addition, healthy individuals with a similar average age to the evaluation group without any disease diagnosis will be included in the study as a control group. Evaluations of the healthy group will be made once by the researchers and will take approximately one hour. Data will be collected face to face at the Faculty of Physical Therapy and Rehabilitation, Rheumatology Unit. Data collection tool of the research: * Information about patients will be recorded with the Demographic Information Form. * EULAR Sjögren's Syndrome Disease Activity Index * EULAR Sjögren's Syndrome Patient Reporting Index * Primary Sjögren's Syndrome Quality of Life Scale * BETY-Biopsychosocial Questionnaire * Central Sensitization Scale * Pain Catastrophizing Scale * Hospital Anxiety and Depression Scale * Multidimensional Fatigue Rating Scale * Turkish Eating Assessment Tool * Yale Swallow Protocol * Test of Mastication and Swallowing Solids * Dysphagia Limit Test * Xerostomia inventory
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 6 May 2024
- Start date
- 19 Jun 2024
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Kahramanmaras Sutcu Imam University
- Diseases
- Sjögren's disease
- NCT number
- NCT06410742
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 19 Jun 2024 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with Secondary Sjögren's Syndrome,
- Patients who are diagnosed with other uncontrolled/clinically important diseases (chronic obstructive pulmonary disease, congestive heart failure, endocrine system diseases, neurological, psychological diseases, etc.),
- Having a malignant condition,
Other
- Pregnant individuals in the third trimester,
- Individuals who do not agree to participate in the study and do not give written consent will be excluded from the study.
Who the study is looking for
- Patients diagnosed with Primary Sjögren's Syndrome
- 18 years or older
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nazli Elif Nacar Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.